Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1044

1.

VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.

Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM.

J Rheumatol. 2002 Oct;29(10):2114-21.

PMID:
12375320
2.

VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.

van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, Albano SA, Teng NN.

J Rheumatol. 1999 Aug;26(8):1727-33.

PMID:
10451069
3.

Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.

Stevenson FK, Longhurst C, Chapman CJ, Ehrenstein M, Spellerberg MB, Hamblin TJ, Ravirajan CT, Latchman D, Isenberg D.

J Autoimmun. 1993 Dec;6(6):809-25.

PMID:
8155258
4.
5.

Molecular and genetic characterization of two anti-DNA antibodies derived from patients with systemic lupus erythematosus.

Song YW, Kim HA, Lee EB, Baek HJ, Kim JK, Chung JH, Chung ES, Hong KM.

Rheumatol Int. 1998;17(6):223-8.

PMID:
9592861
7.

Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.

Yoshio T, Masuyama J, Ikeda M, Tamai K, Hachiya T, Emori T, Mimori A, Takeda A, Minota S, Kano S.

J Rheumatol. 1995 Sep;22(9):1681-7.

PMID:
8523345
8.

Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.

Saxena R, Sturfelt G, Nived O, Wieslander J.

Ann Rheum Dis. 1994 Oct;53(10):659-65.

9.

Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.

Caccavo D, Rigon A, Picardi A, Galluzzo S, Vadacca M, Ferri GM, Amoroso A, Afeltra A.

Clin Rheumatol. 2005 Aug;24(4):381-7. Epub 2004 Dec 9.

PMID:
15592902
11.

Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes.

Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I.

J Immunol. 2004 Apr 1;172(7):4298-307.

12.

IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies.

Bhat NM, Kshirsagar MA, Bieber MM, Teng NN.

Immunol Invest. 2015;44(4):400-10. doi: 10.3109/08820139.2015.1015682.

PMID:
25942350
13.

Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.

Amoroso A, Mitterhofer AP, Del Porto F, Garzia P, Ferri GM, Galluzzo S, Vadacca M, Caccavo D, Afeltra A.

Hum Immunol. 2003 Feb;64(2):265-73.

PMID:
12559629
14.

Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.

Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.

PLoS One. 2013 Aug 12;8(8):e71458. doi: 10.1371/journal.pone.0071458. eCollection 2013.

15.

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.

Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, Kallenberg CG.

Ann Rheum Dis. 1997 Nov;56(11):661-6.

16.

Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.

Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC, Kotzin BL.

Am J Med. 1991 Jan;90(1):54-62.

PMID:
1986591
17.

Antidouble-stranded DNA isotypes in lupus erythematosus patients with prevalent cutaneous presentation.

Parodi A, Drosera M, Barbieri LB, Babbini G, Rebora A.

Br J Dermatol. 2002 Oct;147(4):754-6.

PMID:
12366424
18.
19.

Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus.

Song J, Park YB, Lee WK, Lee KH, Lee SK.

Rheumatol Int. 2000 Dec;20(1):1-7.

PMID:
11149654
20.

Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II.

Bhat NM, Bieber MM, Hsu FJ, Chapman CJ, Spellerberg M, Stevenson FK, Teng NN.

Clin Exp Immunol. 1997 Apr;108(1):151-9.

Supplemental Content

Support Center